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Abstract
Background: This study describes the design, optimization, and stress-testing of a novel phytocannabinoid
nanoemulsion generated using high-pressure homogenization. QNaturale , a plant-derived commercial emulsifier
containing quillaja saponin, was used to stabilize the lipid phase droplets in water. Stress-testing was performed on
this nanoemulsion in order to evaluate its chemical and colloidal stability under the influence of different
environmental factors, encompassing both physical and chemical stressors.
Methods: Extensive optimization studies were conducted to arrive at an ideal nanoemulsion formulation. A coarse
emulsion containing 16.6 wt% CBD-enriched cannabis distillate and 83.4 wt% carrier (soybean) oil dispersed in 10 wt%
QNaturale (1.5 wt% quillaja saponin) solution after 10 homogenization cycles at a pressure of 30,000 psi produced a
stable nanoemulsion. This nanoemulsion was then subjected to the stress studies.
Results: The optimized nanoemulsion had an average droplet diameter of ca. 120 nm and average droplet surface ζ
potentials of ca. -30 mV. It was imaged and characterized by a variety of protocols. It proved to be stable to droplet
agglomeration and phase separation upon storage under ambient conditions for 6 weeks, as well as under a variety of
physical stressors such as heat, cold, dilution, and carbonation. pH values ≤2 and moderately high salt concentrations
(> 100 mM), however, destabilized the nanoemulsion, eventually leading to phase separation. Cannabis potency,
determined by HPLC, was detrimentally affected by any changes in the nanoemulsion phase stability.
Conclusions: Quillaja saponin stabilized cannabidiol(CBD)-enriched nanoemulsions are stable, robust systems even at
low emulsifier concentrations, and are therefore significant from both a scientific as well as a commercial perspective.
Keywords: Cannabis, Nanoemulsion, High pressure homogenization, Stress testing

Background
As the therapeutic benefits of cannabis become scientifically established, and the use of nutraceutical and
recreational cannabis products is decriminalized in countries such as Argentina, Belgium, Georgia, Uruguay, South
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Africa, etc., cannabis research is expected to flourish
in the new decade (McIver 2017). Canada, especially, is
expected to play a pioneering role in cannabis research,
given that it is the only G7 country to have completely
legalized medical as well as recreational cannabis products, whilst simultaneously creating a robust regulatory
system for the purposes of quality assurance and safe
dissemination of cannabis-containing consumer products
(Government of Canada 2018).
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Cannabis is a highly complex mixture, consisting of
over 120 phytocannabinoids with related chemical structures, along with a variety of terpenes and flavonoids
(Turner et al. 2017). As many of these natural products
interact with the central nervous system (CNS) receptors (Zou and Kumar 2018), cannabis could prove to be
an exceedingly promising source for pharmacophore discovery. Amongst the phytocannabinoids, 9 - tetrahydrocannabinol (THC) and cannabidiol (CBD) are by far the
most abundant, and consequently, the most thoroughly
examined (Hanus et al. 2016; Reekie et al. 2017). THC and
CBD have demonstrated neuroprotective, immunomodulatory, as well as anti-inflammatory effects (Cameron and
Hemingway 2020), leading to their inclusion as adjunctive
treatment for malignant brain tumors, Parkinson’s disease, Alzheimer’s disease, multiple sclerosis, neuropathic
pain, and childhood seizure disorders (Maroon and Bost
2018). Experimental studies are being conducted in order
to examine anecdotal and preliminary scientific evidence
of their benefits in alleviating psychiatric and mood disorders, such as schizophrenia, anxiety, depression, addiction, and post-traumatic stress disorder (Shahbazi et al.
2020; Scherma et al. 2018). While the psychoactivity
of THC can be less desirable in some clinical settings,
the non-psychoactive CBD, with its anti-inflammatory,
anti-convulsive, and anti-emetic effects, is a prime candidate for the development of functional cannabinoid-based
nutraceuticals (Parker et al. 2002; Khan et al. 2020). Other
promising biological effects of cannabinoids include antiobesity and antidiabetic effects of tetrahydrocannabivarin
(THCV) (Abioye et al. 2020) and in developing fluorideand alcohol-free anti-bacterial mouthwash and oral care
products (Vasudevan and Stahl 2020).
CBD is highly lipophilic and hydrophobic, thereby making oral delivery routes for CBD an essential but underexplored field of research (Grotenhermen 2003). CBD has
low oral bioavailability (ca. 6–9%) owing to its low aqueous solubility and its susceptibility to ready clearance during first pass metabolism; therefore, it is up to the formulation science community to devise new routes for orally
administering cannabinoids to both increase and ensure
reproducibility of blood plasma concentrations (Elgart et
al. 2012). Protocols such as self-emulsifying drug delivery
systems have been applied in the past to increase solubility
and reduce first pass metabolism of lipophilic bioactives
such as cannabinoids in the context of pharmaceutical
preparations (Cherniakov et al. 2017).
A potential approach used to augment the bioaccessibility of orally administered lipophilic nutraceuticals is their
incorporation into nanoemulsions (Jaiswal et al. 2015;
Solans et al. 2005). Due to reduced droplet sizes and lower
emulsifier concentrations in these systems relative to
microemulsions or liposomes, loading of phytocannabinoids in the lipid phase of nanoemulsions may improve
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drug bioaccessibility (Acosta 2009), prevent oxidative
degradation of the cannabinoids (Sun et al. 2015), and
provide a more palatable and “label friendly” cannabinoid
ingestible (Raikos and Ranawana 2017).
A stable nanoemulsion has a bulk phase (here, water);
a diffused phase (here, a solution of cannabis extract
in an edible oil); and an emulsifier. The emulsifier is
of paramount importance: not only does it prevent the
lipid phase droplets from agglomerating and undergoing
phase-separation, but it also dictates the taste and ‘mouthfeel’ of the resultant nanoemulsion (Mouritsen and Styrbaek 2017; Panghal et al. 2019). Excess emulsifier may very
well imbue an emulsion with a bitter ‘chemical’ or metallic
taste, or an unpleasant texture; moreover, cost, safety and
regulatory issues also come into play. Naturally occurring,
‘label-friendly’ emulsifiers are therefore preferred when
devising such nanoformulations. QNaturale is a commercially available emulsifier containing quillaja saponin
obtained from the bark of the quillaja saponaria Molina
tree. It has previously been found to be effective for
the fabrication of nanoemulsions by high-energy methods
such as microfluidization (Bai et al. 2016). Structurally,
quillaja saponin might best be described as a mixture
of triterpenoid saponins comprising a hydrophobic quillaic acid backbone glycosylated with hydrophilic sugar
moieties (Fig. 1). The interfacially active saponins in quillaja extracts consist of two hydrophilic sugar chains and
one hydrophobic aglycone, generating a three-unit structure with distinct hydrophilic–hydrophobic–hydrophilic
properties (Reichert et al. 2019). The emulsion-stabilizing
properties of QNaturale are attributed to strong electrostatic repulsion in quillaja saponin coated lipid droplets
with high negative surface ζ -potentials between pH 3
and 9 (Kharat and McClements 2019; Zhu et al. 2019).
Additionally, the fast adsorption kinetics of QNaturale
onto lipid droplet surfaces also promotes the formation of stable quillaja saponin oil-in-water nanoemulsions
with sub-μm droplet sizes (Bai et al. 2016; Zhang et al.
2016). Another important component is the carrier oil,
which modulates emulsion stability and bioactive bioaccessibility. For the purposes of this study, soybean oil,
a biodegradable, non-toxic, and sustainably sourced edible oil was selected owing to its excellent miscibility with
cannabis extracts (Hsu and Nacu 2003). Soybean oil and
soy protein isolates have been used in the past as carrier
media for pharmaceuticals (Takino et al. 1994; Chung et
al. 2001) and nutraceuticals (Teng et al. 2012; Chen and
Subirade 2009).
This report adds to the few published accounts of
cannabinoid emulsions as potential medicinal and/or
nutraceutical products. Recently, Marangoni et al.
reviewed THC encapsulation and stability in food
matrices (Marangoni and Marangoni 2019); similarly,
McClements has reviewed scientific developments in the
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Fig. 1 General chemical structure of Quillaja saponin; R1,2,3,4 represent saccharide or acyl residues. Adapted from Reichert et al. (2019)

emerging field of cannabis-enriched foods (McClements
2020). In an in vivo study on bile-fistulated rats, Sato
and colleagues examined a medicinal CBD emulsion
containing very high doses of polyethylene glycol sorbitan monolaurate (tween-20) (70% w/w); the intestinal
absorption of CBD and its pharmacokinetic profiles in
rats were determined (Nakano et al. 2019). The effect
of bile secretion on the intestinal absorption of CBD
from oil and emulsion was also studied — these emulsions, however, were clearly unsuitable candidates for
nutraceuticals owing to the excessive tween-20 content.
Self-emulsifying drug delivery systems were utilized by
Sacks and colleagues in 2018 for a novel THC/CBD capsule formulation (Atsmon et al. 2018). Similarly, Knaub
et al. in 2019 studied a novel CBD nanoemulsion generated in situ within the human gastrointestinal tract; this
formulation was based on VESIsorb® formulation technology (Knaub et al. 2019). However, the focus of these
two studies were on oral bioavailability of cannabinoids in
human test subjects rather than on the preparation of the
CBD nanoemulsion. In 2020, Peshkovsky and colleagues
published an account of a tween-80/span-80 stabilized
CBD-containing nanoemulsions generated using a benchscale ultrasonic liquid processor; they also demonstrated
the scalability of their emulsification process (Leibtag and
Peshkovsky 2020). Unfortunately, none of these studies
employed a rational design approach suitable for the
creation of nutraceutical-standard cannabis-enriched
nanoemulsions; furthermore, the nanoemulsions were
not assessed for colloidal and/or chemical stability and
cannabis potency under non-ideal environmental conditions. The present study addresses this issue by rational
design of a stable, robust CBD-infused nanoemulsion.
Concomitantly, it examines the impact of parameters
such as lipid-to-emulsifier ratio, composition of the lipid

phase, and the number of homogenization cycles on the
droplet sizes of the nanoemulsion and its CBD concentration values, de facto measures of the emulsion quality
and stability. The resultant optimized nanoemulsion
was then submitted to a variety of stressors mimicking
production and storage conditions relevant to the beverage industry. Optical microscopy and scanning electron
microscopy (SEM) are used to examine the impact of pH
and additional electrolyte concentration on nanoemulsion droplet sizes, and by proxy, the overall stability of the
system. This multi-factorial approach analyzing potential
commercially-relevant cannabis nanoemulsions aims to
provide us with detailed insight into their emulsion properties. This account of a stable, robust and plant-sourced
cannabinoid nanoemulsion is expected is to be the first of
a series of reports on the design, fabrication, and testing
of cannabis-based nutraceutical products.

Materials and methods
Materials

QNaturale 200V (14–16 wt% quillaja saponin; Ingredion, New Jersey) was used as received. Soybean oil
was sourced from Jeen International Corporation (New
Jersey) and used without further purification. CBDenriched cannabis distillate (CDCBD ) was donated by
XTRX (Ontario, Canada) and was used as received; the
cannabinoid composition of the CDCBD may be found in
Table S1 (SI). The preservative potassium sorbate (Nantong Acetic Acid Chemical Co., China) was added to
the coarse emulsions prior to high pressure homogenization. HPLC grade water (EMD Millipore) was used in
all experiments. Sucrose and CaCl2 were purchased from
Sigma Aldrich. For the measurement of pH, a freshly calibrated pH-meter (Milwaukee MW102 PRO+) was used.
For the HPLC analysis, 1 mg/mL stock solution of each
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of the following cannabinoids was obtained from Cerilliant: cannabidiolic acid (CBD-A), tetrahydrocannabinolic acid (THC-A), cannabidiol (CBD), cannabigerolic
acid (CBG-A), cannabigerol (CBG), cannabichromene
(CBC), cannabinol (CBN), and delta-9 tetrahydrocannabinol (THC).
Preparation of the nanoemulsions

A representative nanoemulsion was synthesized as follows: the CDCBD (69% CBD; see Table S1) was magnetically stirred and heated in a water bath at ca. 65◦ C, and
to it was added the requisite weight of the soybean oil
in order to create a homogeneous lipid phase. The stirring was continued for another 10–15 min. Meanwhile,
QNaturale was dissolved in water in order to generate the aqueous phase. Finally, the lipid phase was added
to the water phase in the correct proportion (usually, 10
wt% lipid phase in water) while subjecting the mixture to
three cycles of blending using a high shear mixer (IKA-T1000) at ambient temperatures (60 s on, 60 s off at power
setting = 3). This generated a milky coarse emulsion, to
which was added 0.1 wt% potassium sorbate, and enough
citric acid to lower the pH to ∼3.4–3.8. The nanoemulsions were then formed by passing the coarse emulsions
through a high pressure homogenizer (Nano DeBee, BEE
International, USA; equipped with a chill loop) at a pressure of 30000 psi. The number of passes were optimized
during the course of the study (vide infra). Finally, the
nanoemulsions were poured in glass vials, capped, and
stored either in a fridge at ∼4◦ C in amber vials (for
long term storage) or under ambient conditions in the
dark (for short-term storage). The CBD concentration of
the final emulsion was determined to be 10–11 mg.g −1
(slight variations are attributed to individual lots of emulsions made) on the basis of measured weights, although
quantitative analysis of the nanoemulsion revealed
slight loss of CBD during the emulsion preparation
(vide infra).
Emulsion droplet size distributions

In order to determine lipid particle size distributions in
the nanoemulsions, dynamic light scattering (DLS), also
known as photon correlation spectroscopy, was applied.
This technique generated Z-average diameters of the dispersed phase droplets (dz ), as well as the polydispersity
index (PDI). Diluted samples (50- to 100-fold dilutions)
were used to avoid multiple scattering. The measurements
were conducted with the Zetasizer (Nano ZS, Malvern
Instruments Ltd., UK). dz was calculated from the autocorrelation function of the intensity of light scattered
from the particles. The software used was Zetasizer Software 7.13, supplied by the manufacturer (Malvern Instruments Ltd.) Disposable poly(styrene) cuvettes (ZEN0040)
were used for sample measurements. Phase-separated
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nanoemulsions were re-mixed by shaking prior to dilution
for DLS measurements.
Emulsion droplet zeta potential distributions

The rate of droplet movement under the influence of an
external oscillating electrical field with a voltage of 150
V (electrophoretic mobility) was measured with the Zetasizer (Nano ZS, Malvern Instruments Ltd., UK) in folded
capillary zeta-cells obtained from Malvern (DTS1070).
The measured electrophoretic mobilities were converted
to ζ -potentials by the instrument software (Zetasizer Software 7.13, Malvern Instruments Ltd., UK) using Henry’s
equation:
Ue =

2εζ
.faκ
3η

(1)

where Ue is the electrophoretic mobility, ε is the dielectric constant, ζ is the zeta potential, η is the viscosity of
the dispersant, and faκ is the Henry function. The Smoluchowski approximation, faκ = 1.5, was used for high ionic
strength media, given that water was the bulk phase in all
the measured emulsions (Sze et al. 2003).
Optical microscopy

For optical microscopy, 10 μL of the nanoemulsion was
placed on a clean glass slide. A glass cover-slip was then
positioned upon the droplet, and sealed in place with
transparent nail-polish. Samples were examined and photographed immediately under an Olympus BX-51 microscope equipped with an Olympus U-CAMD3 camera
under bright-field conditions at a magnification of 50x.
Scanning electron microscopy (SEM)

SEM was performed on an FEI Nova NanoSEM430.
Nanoemulsion droplets were dispersed on polished silicon (100) chips and dried, followed by sputter coating to
5–6 nm with iridium using a Lecai EM ACE600 system.
For cryo-SEM, an FEI Helios NanoLab 650 FIB/SEM system equipped with Quorum PP3010T cryo system was
used. Sample imaging temperature was -140◦ C, and sublimation was -70◦ C for 10 min. SEM images were analyzed
using ImageJ (Abramoff et al. 2004).
Stress testing

As a metric of stress-induced nanoemulsion instability, we
calculated % change in nanoemulsion droplet sizes (dz ) as
follows:


dz,f − dz,i
× 100
(2)
%dz =
dz,i
where dz,f is the z-average nanoemulsion droplet size after
the application of the stressor, and dz,i is initial value
for dz .
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The same quantity for variations in ζ potential values is
defined as follows:


ζf − ζi
× 100
(3)
%ζ =
ζi
where ζf is the ζ potential of the nanoemulsion after
the application of the stressor, and ζi is initial value. For
the purposes of this study, negative values of %ζ indicate destabilization by shifting of the ζ potential value
towards zero from either direction, while a positive %ζ
indicates a shift to numerically greater ζ potential values
with attendant increase in interdroplet repulsions.
Long-term storage

To examine the effect of long term storage on the colloidal
and chemical stability of the nanoemulsion, we stored
them in tightly capped amber glass vials in a refrigerator
at 4◦ C. Aliquots were periodically removed from the vials
and diluted prior to DLS measurements. Measurements
were performed immediately after high pressure homogenization, and after that, once every seven days for up to
six weeks.
Flash heating

1 g of the optimized nanoemulsion was placed in a preheated water bath and the internal temperature of the
nanoemulsion was maintained at 80◦ C for 1 minute.
This protocol is a more extreme version of the hightemperature short-time (HTST) pasteurization process
(typically, 71.5◦ C for 15 s) that fruit juices and milk beverages are subjected to in the industry (Negiz et al. 1998).
The nanoemulsion was then allowed to cool to room temperature, and a part of it was diluted for DLS study. The
rest was retained for cannabis potency evaluation.
Freeze-thaw cycle

1 g of the optimized nanoemulsion was placed in a freezer
at a temperature of -20◦ C for 1 hour; then, the nanoemulsion was removed from the freezer and allowed to revert
to room temperature. A part of the thawed nanoemulsion
was diluted for DLS study, and the rest was retained for
cannabis potency evaluation.
Dilution and carbonation

In a representative study, 1 mL of a representative
cannabis nanoemulsion containing ca. 10 mg CBD was
diluted to 355 mL (volume of a standard beverage can)
using HPLC-grade water, thereby setting the CBD content at 10 mg per packaging unit. The diluted emulsion
was then subjected to dynamic light scattering measurements. Given the absence of any stressors that might lead
to cannabis decomposition or physical separation during
this procedure, a potency evaluation wasn’t performed. It
is to be noted that the diluted nanoemulsion was almost
transparent, which is a property sought by manufacturers
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of cannabis-enriched carbonated-water type beverages
(Donsi 2018; Saari and Chua 2020).
For the carbonation study, a similar protocol was
adopted; however, for the dilution of 1 mL nanoemulsion concentrate to 355 mL, carbonated water obtained
from a domestic Sodastream unit operating in the
“medium level of carbonation” mode was used. The resultant diluted beverage, containing approximately 10 mg of
CBD, had a pH of 3.8.
Change in pH

1 g aliquots of the optimized CDCBD nanoemulsion were
withdrawn at a starting pH of 3.6, and the pH of these
aliquots were adjusted by the addition of 0.25 or 0.025(M)
HCl or NaOH solution to values ranging from 1.9 to 9.4.
The final weights of all aliquots were adjusted to the same
value with HPLC water. After an incubation period of
12–18 h, these were diluted with solutions of matched
pH values and subjected to DLS studies for measurement
of average droplet diameters and zeta potentials. Meanwhile, cannabis potency evaluations were performed on
the undiluted pH-adjusted aliquots.
Ionic and covalent additives

In a representative experiment, varying masses of CaCl2 ·
2 H2 O were added to 5 mL portions of the optimized
nanoemulsion so as to span a salt concentration range
between 1 and 250 mM. To ensure complete dissolution of
the salt, the aliquots were vortexed for 1 min each. After
an incubation period of 12–18 h, it was noted that in vials
with [CaCl2 · 2 H2 O] ≥100 mM, the nanoemulsions had
partially or totally phase-separated (Figure S3). In order
to perform the DLS studies, the aliquots were vortexed
again for 1 min prior to dilution with calcium chloride
solutions.
A similar protocol was followed to observe the impact
of the addition of model non-ionic additive (here, sucrose,
a sweetener) to a CDCBD nanoemulsion. To 5 mL portions of the optimized nanoemulsion were added varying
masses of sucrose so as to span a sucrose concentration
range between 1 and 500 mM (for reference, a 355 mL can
of Coca-Cola typically has 39 g of sugar (The Coca-Cola
Company 2021), which amounts to a sugar concentration of ca. 320 mM, assuming all the sugar is sucrose). To
ensure complete dissolution of the sucrose, the aliquots
were vortexed for 1 min each. After an incubation period
of 12–18 h, 1 mL of aliquot was withdrawn from each sample in preparation for DLS evaluation. It is to be noted that
cannabis potency studies were not carried out in the context of salt and sugar addition to the nanoemulsions, given
that neither is expected to degrade cannabinoids and any
cannabis potency loss from the bulk of the solution may
be attributed to phase separation rather than to chemical
transformations.

(2021) 3:43
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MCT oil/water interface at 1 wt% quillaja saponin) leads
to its rapid absorption at the lipid/water interface, and
consequent stabilization of the resultant emulsions, even
at low emulsifier concentrations (Chung et al. 2017). It is,
however, of utmost importance to optimize the emulsifier
wt%. We synthesized 10 wt% soybean oil nanoemulsions
with 0.5, 1.5, 2.5, 5, 10, and 15 wt% of QNaturale , and
after 10 homogenization cycles at 30 Kpsi, observed the
lipid phase droplet sizes and ζ potentials (Fig. 2a). The difference between the average diameters of the lipid phase
droplets of a nanoemulsion containing 0.5 wt% emulsifier and one containing 1.5 wt% emulsifier was about 125
nm. In contrast, when the emulsifier concentration was
varied from 5 wt% to 10 wt%, this difference was only
about 12 nm. Upon further increasing the QNaturale
concentration to 15 wt%, the emulsion clearly enters an
‘emulsifier-rich region’, and the droplet sizes become independent of the emulsifier concentration (McClements
2015). It is to be noted that the droplet sizes recorded by
us (ca. 120 nm) matches well with the values recorded
by Leibtag et al. for their olive oil/CBD/quillaja saponin
nanoemulsion produced by a sonication method (ca. 110
nm), indicating a lower bound for quillaja saponin stabilized CBD/carrier oil droplets in the aqueous phase of
a nanoemulsion, regardless of the emulsion preparation
method (high pressure homogenization versus ultrasonic
cavitation) or carrier oil type (soybean oil versus olive
oil) (Leibtag and Peshkovsky 2020). It was suggested that
this lower bound was a function of the character and
packing capabilities of the surfactants. Similarly, more
negative ζ potential values were recorded at intermediate QNaturale concentrations. The samples also showed
enhanced monodispersity at greater emulsifier concentrations (Fig. 2b). These quantities, upon being remeasured
after a week of storage under ambient conditions, did not
exhibit any major deviations from their original values,
other than demonstrating a smaller dependence of the ζ
potential on the QNE wt%. For further experiments, we

Quantification of cannabis by HPLC

Quantitative cannabinoid analysis was performed at RPC,
New Brunswick’s provincial research organization (PRO),
a research and technology organization (RTO) offering
contract research and technical services in Fredericton.
Cannabinoids were analyzed using an Agilent 1200 series
HPLC system. Separation of cannabinoids was performed
with a Phenomonex C18 column (Luna 5 μm, 5.6 mm I.D.
X 150 mm). The mobile phase was acetonitrile (A) and 25
mM ammonium formate solution (pH 3.75) (B) at a flow
rate of 1 ml/min. The isocratic flow was 80% (A), 20% (B).
The diode array detector was set at 228 nm. All solvents
used were HPLC-grade and filtered via 0.20-μm filters.
For calibration purposes, the cannabinoid standards
(vide supra) were mixed at concentrations of 1 ppm,
2 ppm, 10 ppm, 20 ppm and 100 ppm. For analysis,
100 mg of sample was extracted with 30 mL of 90:10
methanol:chloroform, vortexed for 20 seconds and placed
in an ultrasonic bath for 20 minutes. Afterwards, sample
was centrifuged at 1200 rpm for 5 minutes. Supernatant
was filtered using a 0.20 μm filter, and fed into the HPLC.
Statistical analysis

All DLS measurements were carried out in triplicate
on at least two samples. Mean and standard deviations
were calculated using Microsoft’s Excel spreadsheet package (2016). For zeta potentials, the error bars represent the zeta deviation values obtained directly from the
instrument.

Results and discussion
Optimization of emulsifier wt%

In nanoemulsions, the use of the least possible amount
of emulsifier necessary to create a stable emulsion is
recommended (vide supra). This is one of the primary
justifications for the use of QNaturale (15 wt% quillaja
saponin) in our nanoemulsions: its low molecular mass
and facile reduction of interfacial tension (ca. 5 mN/m for
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Fig. 3 Variation of a dz , b ζ potentials, and c PDI as a function of the number of homogenization cycles for a cannabis-free soybean oil nanoemulsion

selected a QNaturale concentration of 10 wt%, which
roughly equated to a quillaja saponin concentration of
approximately 1.5 wt% in the resultant nanoemulsion.
Optimization of number of homogenization cycles

Before the introduction of the CDCBD within the
nanoemulsion, we attempted to optimize factors such as
the number of homogenization cycles, too few of which
would lead to larger droplet sizes with attendant instability, while an excessive number would not only be operationally inefficient and expensive, but might also lead to
emulsifier degradation and reduced colloidal stability of
the emulsions (Peng et al. 2015). Therefore, we carried
out 10 consecutive homogenization cycles at 30 Kpsi on
a 10 wt% soybean oil nanoemulsion containing 10 wt%
QNaturale (Fig. 3), sampling aliquots after each processing cycle. There was a large reduction in soybean oil
droplet sizes after the initial couple of homogenization
cycles - dz values changed from ca. 450 nm for the coarse
emulsion, to 185 nm after one homogenization cycle, and
to 165 nm after the second homogenization cycle. After
this, the size largely stabilized; in fact, droplet size differences were within the limits of experimental error after
8–9 homogenization cycles. Therefore, we selected 10 as
the optimal number of homogenization cycles for the generation of stable nanoemulsions. The entire high-pressure
homogenization process for a coarse emulsion weighing
ca. 40 g took 9.6 minutes for 10 homogenization cycles. ζ
potential values of the droplets showed a slight reduction
(ca. 10 mV) over this range, possibly owing to detachment of charged moieties from the structure of quillaja
saponin, caused either by the homogenization itself, or
by the resultant localized heating within the emulsion
during the process (Rampon et al. 2003; Floury et al.
2003). This experiment was repeated with the optimized
cannabis nanoemulsion (vide infra) in order to evaluate
the impact of the number of HPH cycles on cannabis

potency (Fig. 4), with the measured weight of the CBD
used in the emulsion preparation taken as 100%. Considering the CBD concentration in the nanoemulsion as
a metric of cannabis potency, we found that the CBD
concentration did not change beyond the limits of experimental error after the first two cycles, thereby indicating
that CBD decomposition over 10 homogenization cycles
is not a concern (Fig. 4). Incomplete mixing of the two
phases and/or slight phase separation upon storage leading to heterogeneity in the samples explained the lower
[CBD] values in the samples corresponding to the first two
homogenization cycles analyzed by HPLC. Variation of

Fig. 4 Variation of CBD% in nanoemulsion as a function of the
number of homogenization cycles for a CDCBD nanoemulsion

(2021) 3:43
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Table 1 ζ potential values of CDCBD nanoemulsions with varying
lipid phase compositions
Day

CDCBD % a

ζ (mV)

ζ deviation (mV)

1

10

-33.6

7.6

1

75

-28.1

5.7

8

10

-30.6

7.1

8

75

-21.1

7.4

of the lipid phase composition, as well as upon prolonged
storage (Table 1). Further experiments were conducted
with the lipid phase containing 16.6 wt% of CDCBD .
Imaging the optimized cannabis/soybean oil-in-water
nanoemulsion

a
Percentage CDCBD in the lipid phase; soybean oil is the other lipid phase
component

the optimized nanoemulsion droplet sizes with the number of homogenization cycles were comparable to those
recorded for the cannabis-free nanoemulsion (Figure S2).
Optimization of lipid phase composition

In preliminary experiments, we noticed that cannabisheavy lipid phases were more viscous and in general
more difficult to handle. Moreover, nanoemulsions made
with cannabis-majority lipid phases had broad, bimodal
droplet size distributions and tended to exhibit droplet
agglomeration upon prolonged storage. Therefore, we fabricated a series of lipid phases with varying CDCBD contents (100, 75, 50, 25, 16.6, and 10 wt% of CDCBD ) mixed
with appropriate amounts of soy oil. These were then used
to generate 10 wt% lipid phase nanoemulsions containing 10 wt% QNaturale as described before. Dispersed
phase droplet sizes, polydispersity index values, and ζ
potentials were measured for these systems both immediately after creation, as well as after 7 days under ambient
storage conditions. It is evident that the average lipid
phase droplet sizes decrease (Fig. 5a) and the dispersion
becomes monodisperse (Fig. 5b, Figure S2) as the cannabis
oil wt% is reduced, potentially owing to the higher viscosity of the cannabis extract compared to soybean oil. The ζ
potentials, on the other hand, remain relatively unchanged
within the limits of experimental error, both as a function

Representative SEMs of the optimized CDCBD nanoemulsion may be found in Fig. 6. The size distribution, calculated from data obtained by measuring the diameters
of >250 droplets, revealed the average droplet size to be
115 nm (SD= 39 nm), which is somewhat smaller than the
DLS size data. This, however, is not unexpected, since DLS
tends to ‘over-weigh’ larger particles owing to their greater
light-scattering ability (Souza et al. 2016). Moreover, DLS
considers a layer of water molecules surrounding the
lipid droplet, generating what is called the hydrodynamic
radius, which is inevitably greater than the actual radius of
the lipid droplet.
In the presence of 50 mM CaCl2 · 2 H2 O, the nanoemulsion droplets show an increase in size, with the average
droplet diameter increasing to 165 nm (SD= 48 nm); this
trend is in agreement with the DLS data. Optical micrographs of the optimized nanoemulsion with and without
additives maybe found in Figure S5 as well as insets in the
appropriate graphs.
Impact of physical stressors

The impact of physical stressors on the stability and
potency of cannabis in the optimized cannabis nanoemulsion have been summarized in Table 2, with the dz,f and ζf
values obtained from measurement of control nanoemulsion samples sans exposure to stressors. On the basis of
the %dz values, we conclude that pasteurization-style
flash heating and a single freeze-thaw cycle at -20◦ C has
minimal impact on the nanoemulsion parameters except
a slight increase in droplet sizes. Dilution to 355 mL,
using either still or carbonated water, reduces average

(b)

(a)
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275
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225
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s iz e (nm)

Day 8

Day 8
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Day 1
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0
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0
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0
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2
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0

0

1

1
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Fig. 5 Variation of a dz and b PDI of a phytocannabinoid nanoemulsion, immediately upon fabrication, and after a week, as a function of the wt% of
CDCBD in the lipid phase of the nanoemulsion
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Fig. 6 a SEM of the optimized nanoemulsion, showing lipid phase droplets; (inset) close-up of the nanoemulsion droplets; b SEM of the
nanoemulsion in the presence of 50 mM CaCl2 . Size distribution profiles are underneath the respective SEMs

droplet size slightly, while droplet size distribution profiles
remain unaltered, which confirms that our nanoemulsion is kinetically metastable. However, upon storage of
the nanoemulsion for 6 weeks under ambient conditions,
slight ’ringing’ (creation of a very thin whitish creamy ring
on the glass surface at the top of the emulsion) (Kumar
and Sarkar 2018) was observed, likely due to difference in
density between the oil and water phases, and the ζ potential values fell. Concentration of CBD in the optimized

nanoemulsion decreased by ca. 17% after 6 weeks of storage upon comparison to the initial concentration of CBD
in the freshly synthesized nanoemulsion (Fig. 7).
Impact of chemical stressors

In practical applications, cannabinoid nanoemulsions are
expected to retain their desirable emulsion properties
over a wide range of pH values and ionic strengths,
depending upon product composition. Factors such as

Table 2 Impact of stressors on optimized CDCBD nanoemulsion parameters
dz,f (nm)

%dz

ζf (mV)

%ζf

[CBD] (mg.g−1 )

System

Stressor

1a

none

125.5

N/A

-32.2

N/A

10.8

2

heat

136.8

9

-30.9

-4

10.4

3

freeze-thaw

142.5

13.5

-30.2

-6.2

10.6

4

dilutionb

123.6

-1.5

-25.6

-19.7

N/Ac

5

dilution/carbonationd

135.8

-3.5

-25.0

-8.9

N/Ac

6

6 weeks storage

130.0

3.6

-29.4

-8.7

9.1

a

Optimized nanoemulsion, as synthesized
1 mL nanoemulsion added to HPLC water to obtain a final volume of 355 mL
[CBD] not measured as dilution is not expected to change it
d
1 mL nanoemulsion added to carbonated water to obtain a final volume of 355 mL
b
c
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groups of quillaja saponin leading to reduced interdroplet
repulsion at very low pH values may be invoked to explain
this observation. As expected, zeta potentials became
steadily more negative with increase in pH. These results
indicate that CDCBD nanoemulsions stabilized by quillaja
saponin are stable across most of the pH range present
within food products (pH 3–8), but very acidic matrices

Fig. 7 Variation of CBD concentration (as a % of measured CBD used
in nanoemulsion preparation) in the nanoemulsion, zeta potentials,
PDI, and droplet sizes as a function of the number of weeks of
nanoemulsion storage

pH, the addition of ionic salts, and organic additives such
as sugars can have profound effects on the stability of
nanoemulsions (McClements 2004).
Effect of pH

Changes in pH can protonate or deprotonate terminal functional groups of emulsifiers, thereby modulating
interdroplet electrostatic repulsive forces, and ultimately
affecting droplet coalescence rates (Chung et al. 2017).
For our optimized nanoemulsion, however, a moderate
increase in droplet size (ca. 30 nm) was observed upon
lowering the pH to highly acidic regime (pH < 2), while no
changes in droplet sizes were recorded upon raising the
pH to 9 (Fig. 8a). Visual observation of the emulsions indicated that creaming occurred at pH 2 and below, which
is consistent with previous reports (Yang et al. 2013);
also, optical microscopy of the optimized nanoemulsion
at pH 1.6 revealed the presence of extensive flocs. These
results seem to indicate that despite minimal particle coalescence, the emulsions show a high degree of flocculation
at pH 2 and below. Protonation of the terminal -COO−

Fig. 8 Variation of dz and ζ potential of the optimized CDCBD
nanoemulsion as a function of: a the pH; b increasing sucrose
concentration. (Inset) optical micrographs of the optimized
nanoemulsion a at pH 3.8 and pH 1.6; b at two different sucrose
concentrations
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might lead to flocculation in such nanoemulsions. Quantitative analysis of emulsions at various pH values indicated a steady concentration of CBD that didn’t change
at different pH values, even after a month of incubation
in the fridge at 4◦ C, suggesting that flocculation in this
case is not accompanied by irreversible phase separation
(Figure S6).
Effect of covalent additives

The addition of varying amounts of sucrose, a commonly
used sweetener, initially caused no changes to the CDCBD
nanoemulsion droplet sizes and ζ potential values; however, lipid droplet sizes begin to increase when the sucrose
concentration exceeds 250 mM (Fig. 8b). At 500 mM
sucrose concentrations, the average droplet sizes of the
optimized CDCBD nanoemulsion increased from ca. 130
nm to ca. 170 nm. From cryo-SEM, average lipid phase
droplet size of the optimized nanoemulsion in the presence of ca. 100 mM sucrose was found to be 182.3 ±48.4
nm, which is in rough agreement with DLS size data
(Figure S4). This observation is explained by the growing
disparity between the density and viscosity of the aqueous
and lipid phases as more and more sucrose is dissolved
in the aqueous phase (McClements 2015). The ζ potential values of the nanoemulsion showed a slight increase
(ca. 10 mV) with increase in sucrose concentration; this
was seen to be reproducible over multiple experiments.
This was likely brought about by the expanding location
of the slipping plane during electrophoretic movement
with increasing concentration of sugars, due to the formation of a viscous hydration layer on the surface of
the nanodroplets, as recorded previously by Matsumoto
(1994). No noticeable changes in the polydispersity index
of the samples were noticed even at the highest sucrose
concentrations.
Effect of ionic additives

The addition of CaCl2 · 2 H2 O was intended to mimic
the effect of hard water; also, essential minerals are often
intentionally added to nutraceutical products (Keowmaneechai and McClements 2002). It is already known that
the addition of salts such as CaCl2 ·2 H2 O can lead to instability and phase separation in nanoemulsions containing
quillaja saponin; nevertheless, it is superior in this context to other emulsifiers such as beet pectins, given that
it offers both electrostatic and steric stability to the lipid
phase droplets (Ralla et al. 2017). Previous studies have
demonstrated the quillaja saponin stabilized nanoemulsions showed droplet aggregation and flocculation at
[NaCl] ≥300 mM (Ralla et al. 2017). In our study, we
found that CDCBD nanoemulsion droplet sizes remained
in the sub-μm region despite some increase in average
diameters at [CaCl2 · 2 H2 O] ≤50 mM (Fig. 6b); at 100
mM, slow but discernible phase separation was initiated,
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while above 100 mM rapid separation of nanoemulsion
into serum layer and creamy layer could be observed
(Figure S3). The primary reason for this observation
is the high screening capacity of the Ca2+ ion, which
reduces the interdroplet Debye screening length, and consequently interdroplet repulsion, until attractive interactions between droplets (such as van der Waal forces)
predominate, leading to droplet coalescence and/or flocculation (McClements 2015). This effect is supposed to
be especially strong in emulsions with ζ -potentials with
magnitudes above 25 mV (as is the case here) in the presence of polyvalent cations (McClements 2015; Ralla et al.
2017) (Fig. 9a). We attempted to measure the ζ -potentials
of our CaCl2 -containing nanoemulsion aliquots,(Fig. 9b)
but the high ionic strengths led to large errors in measured ζ -potential values, possibly owing to effects such
as ion-droplet and droplet-ion-droplet bridging (Dickinson 2010). It is clear, however, that drastic reduction of
ζ -potential could be observed with increasing [CaCl2 ·
2 H2 O], with values dropping to zero between 150 and
200 mM [CaCl2 · 2 H2 O] (Fig. 9b). In order to visualize
our optimized nanoemulsion in the presence of various
additives, optical microscopy was carried out, and the
respective micrographs may be found in the SI (Figure S5).
The relatively high stability of the optimized CDCBD
nanomeulsion may be attributed to the fact that the
creaming rate is directly proportional to the square
of the droplet diameter - an emulsion with nanosized
droplets, therefore, has a reduced rate of gravitational
separation (McClements 2015). Additionally, Brownian
motion effects that favor a homogeneous distribution of
droplets throughout the system counteract the gravitational forces when the droplets are sufficiently small, as
is the case for our optimized nanoemulsion. The charged
-COO− termini present in the quillaja saponin structure
also offers electrostatic stabilization by enhancing interdroplet repulsion. With respect to their chemical stability,
the documented high free radical quenching capacity of
quillaja saponin may help minimize oxidative degradation
of CDCBD within the emulsion lipid phase droplets (Uluata
et al. 2016; Tippel et al. 2017).

Conclusions
This report presents the design, creation, and stresstesting results for a novel cannabidiol-enriched
nanoemulsion as a representative cannabis-containing
nutraceutical suitable for ingestion. After optimization
of the number of high pressure homogenization cycles,
emulsifier wt%, and lipid phase composition, we produced a CBD-enriched soybean oil nanoemulsion in
water in the presence of 1.5 wt% quillaja saponin with
average lipid phase droplet sizes of ca. 120 nm and ζ
potential values of approx. -30 mV. The nanoemulsion
proved to be stable over a period of 6 weeks, with minor
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mM). Cannabis potency, measured in terms of CBD concentration, changed by ∼17% over a period of 6 weeks,
and was largely unaffected by other examined stressors.
It is expected that this report will be the first of a series
stemming from a detailed study of various cannabinoid
nanoemulsions suitable for the nutraceutical industry in
Canada and other countries where the therapeutic potentials of cannabis are finally being widely acknowledged
and commercialized.
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